Australia and New Zealand Acids Market
Description
Australia and New Zealand Acids Market Research, 2033
The Australia and New Zealand acids market was valued at $0.9 million in 2023 and is estimated to reach $1.4 million by 2033, exhibiting a CAGR of 4.6% from 2024 to 2033. As industrial activities grow, the need for acids in applications such as manufacturing, pharmaceuticals, food processing, and water treatment is increasing. Innovations in chemical synthesis, sustainable production methods, and emerging applications in biotechnology and environmental management further contribute to market growth. Moreover, government initiatives supporting industrial expansion and technological progress enhance the adoption of acids in diverse industries, reinforcing their essential role in the region's economic development.
Introduction
Acids are chemical substances that can donate protons (H⁺ ions) or accept electron pairs, typically characterized by their ability to lower pH, react with bases to form salts, and corrode metals. They play a crucial role in various scientific, industrial, and biological processes. Acids are essential in instrumental analysis, research, and quality control (QC) due to their critical role in sample preparation, chemical reactions, and analytical accuracy. High-purity acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid are widely used in laboratories for techniques such as atomic absorption spectroscopy (AAS), inductively coupled plasma mass spectrometry (ICP-MS), and chromatography.
Key Takeaways
The Australia and New Zealand acids market has been analyzed in terms of value ($million). The analysis in the report is provided on the basis of acid type, and country.
The Australia and New Zealand acids market report includes a detailed study covering underlying factors influencing the industry opportunities and trends.
The key players in the Australia and New Zealand acids market are ACE Chemical Company, Agilent Technologies, Australian Scientific Pty Ltd, ChemSupply Australia, Hach, Honeywell International Inc, Rowe Scientific Pty Ltd, SHIMADZU CORPORATION, Thermo Fisher Scientific Inc., and Westlab Pty. Ltd.
The report facilitates strategy planning and industry dynamics to enhance decision making for existing market players and new entrants entering the thermal energy storage industry.
Market Dynamics
The expansion of the chemical industry in Australia and New Zealand is significantly driving the demand for high-purity acids. Industries such as pharmaceuticals, biotechnology, and environmental testing drive the demand for precise and reliable analytical techniques. According to chemistry Australia, in terms of resource utilization the chemistry sector drives more than $286 million of local economic activity for every petajoule of gas it consumes, which is 33 times more than the LNG industry and 68 times more than the gas-fired electricity generation industry. Acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid are essential for laboratory applications such as sample digestion, titration, and pH adjustment. These acids are widely used in techniques such as atomic absorption spectroscopy (AAS), inductively coupled plasma mass spectrometry (ICP-MS), and chromatography, ensuring accuracy in chemical analysis. All these factors are expected to drive the demand for the Australia and New Zealand acids market during the forecast period.
However, the production of acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid depends on key raw materials such as sulfur, ammonia, and chlorine. Fluctuations in the prices of these raw materials, driven by supply chain disruptions, geopolitical tensions, and changes in energy costs, directly impact the cost of producing high-purity acids. Since these acids must meet stringent analytical-grade standards to ensure accuracy in techniques like atomic absorption spectroscopy (AAS), inductively coupled plasma mass spectrometry (ICP-MS), and chromatography, manufacturers face challenges in maintaining consistent quality while managing rising production costs. All these factors hamper Australia and New Zealand acids market growth.
The growing focus on drug discovery, biopharmaceuticals, and vaccine development has increased the demand for precise analytical techniques that rely on ultra-pure acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid. For instance, Commonwealth Scientific and Industrial Research Organisation inaugurated a $23.1 million National Vaccine and Therapeutics Lab in Melbourne. This lab addresses a critical gap in Australia's biomedical sector by enabling the onshore production of vaccines and therapeutics for clinical trials, thereby accelerating the translation of research into viable medical products. Acids play a crucial role in pharmaceutical research by enabling accurate sample preparation, digestion, and chemical analysis in methods such as high-performance liquid chromatography (HPLC), atomic absorption spectroscopy (AAS), and inductively coupled plasma mass spectrometry (ICP-MS). Their ability to ensure the purity, stability, and compliance of pharmaceutical products with stringent regulatory standards makes them essential in both research and manufacturing processes. All these factors are anticipated to offer new growth opportunities for the Australia and New Zealand acids market during the forecast period.
Segments Overview
The Australia and New Zealand acids market is segmented into type and country. On the basis of acid type, market is classified into instrumental analysis, research, and QC. Country-wise, the market is segmented into Australia and New Zealand.
On the basis of type, market is classified into instrumental analysis, research, and QC. Instrument analysis segment accounted for less than two-fifths of the Australia and New Zealand acids market share in 2023 and is expected to maintain its dominance during the forecast period. High-purity acids, such as hydrochloric acid, nitric acid, and sulfuric acid, are essential for dissolving, digesting, and stabilizing samples in laboratories, ensuring accurate and reliable results. Their use in spectroscopy, chromatography, and titration processes is fundamental for precise measurements in industries such as pharmaceuticals, environmental monitoring, and materials science. Moreover, advancements in analytical instrumentation, such as inductively coupled plasma mass spectrometry (ICP-MS) and atomic absorption spectroscopy (AAS), have increased the need for ultra-high-purity acids to minimize interference and enhance detection sensitivity.
Country-wise, the market is segmented into Australia and New Zealand. The Australia country accounted for more than four-fifths of the Australia and New Zealand acids market share in 2023 and is expected to maintain its dominance during the forecast period. The growth of sectors such as biotechnology, nanotechnology, and forensic science is fueling the demand for ultrapure acids, particularly in Australia’s research-driven economy. In addition, sustainability initiatives and the push for green chemistry practices are encouraging the adoption of environmentally friendly acid formulations with reduced impurities, supporting ongoing innovation in analytical research and quality control applications.
Competitive Analysis
Key players in the Australia and New Zealand acids market include ACE Chemical Company, Agilent Technologies, Australian Scientific Pty Ltd, ChemSupply Australia, Hach, Honeywell International Inc, Rowe Scientific Pty Ltd, SHIMADZU CORPORATION, Thermo Fisher Scientific Inc., and Westlab Pty. Ltd.
In the Australia and New Zealand acids market, companies have adopted investment strategy to expand the market or develop new products. For instance, in January 2023, Agilent Technologies Inc. announced an investment of approximately $725 million to double the manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).
Key Benefits of Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Australia and New Zealand acids market analysis from 2023 to 2033 to identify the prevailing Australia and New Zealand acids market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the Australia and New Zealand acids market statistics and segmentation assists to determine the prevailing market opportunities.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the Australia and New Zealand acids market trends, key players, market segments, application areas, and market growth strategies. The research methodology of the global market involves extensive primary and secondary research. Primary research includes about over 12 hours of interviews and discussion with a wide range of stakeholders, including upstream and downstream participants. The primary research typically is the bulk of our research efforts; however, coherently supported by extensive secondary research. Researchers have reviewed over 6,765 product literatures, industry releases, annual reports, and other such documents of key industry participants to obtain better market understanding and gain competitive intelligence. In addition, authentic industry journals, trade associations' releases,and government websites have also been reviewed for generating high-value industry insights.
The Australia and New Zealand acids market was valued at $0.9 million in 2023 and is estimated to reach $1.4 million by 2033, exhibiting a CAGR of 4.6% from 2024 to 2033. As industrial activities grow, the need for acids in applications such as manufacturing, pharmaceuticals, food processing, and water treatment is increasing. Innovations in chemical synthesis, sustainable production methods, and emerging applications in biotechnology and environmental management further contribute to market growth. Moreover, government initiatives supporting industrial expansion and technological progress enhance the adoption of acids in diverse industries, reinforcing their essential role in the region's economic development.
Introduction
Acids are chemical substances that can donate protons (H⁺ ions) or accept electron pairs, typically characterized by their ability to lower pH, react with bases to form salts, and corrode metals. They play a crucial role in various scientific, industrial, and biological processes. Acids are essential in instrumental analysis, research, and quality control (QC) due to their critical role in sample preparation, chemical reactions, and analytical accuracy. High-purity acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid are widely used in laboratories for techniques such as atomic absorption spectroscopy (AAS), inductively coupled plasma mass spectrometry (ICP-MS), and chromatography.
Key Takeaways
The Australia and New Zealand acids market has been analyzed in terms of value ($million). The analysis in the report is provided on the basis of acid type, and country.
The Australia and New Zealand acids market report includes a detailed study covering underlying factors influencing the industry opportunities and trends.
The key players in the Australia and New Zealand acids market are ACE Chemical Company, Agilent Technologies, Australian Scientific Pty Ltd, ChemSupply Australia, Hach, Honeywell International Inc, Rowe Scientific Pty Ltd, SHIMADZU CORPORATION, Thermo Fisher Scientific Inc., and Westlab Pty. Ltd.
The report facilitates strategy planning and industry dynamics to enhance decision making for existing market players and new entrants entering the thermal energy storage industry.
Market Dynamics
The expansion of the chemical industry in Australia and New Zealand is significantly driving the demand for high-purity acids. Industries such as pharmaceuticals, biotechnology, and environmental testing drive the demand for precise and reliable analytical techniques. According to chemistry Australia, in terms of resource utilization the chemistry sector drives more than $286 million of local economic activity for every petajoule of gas it consumes, which is 33 times more than the LNG industry and 68 times more than the gas-fired electricity generation industry. Acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid are essential for laboratory applications such as sample digestion, titration, and pH adjustment. These acids are widely used in techniques such as atomic absorption spectroscopy (AAS), inductively coupled plasma mass spectrometry (ICP-MS), and chromatography, ensuring accuracy in chemical analysis. All these factors are expected to drive the demand for the Australia and New Zealand acids market during the forecast period.
However, the production of acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid depends on key raw materials such as sulfur, ammonia, and chlorine. Fluctuations in the prices of these raw materials, driven by supply chain disruptions, geopolitical tensions, and changes in energy costs, directly impact the cost of producing high-purity acids. Since these acids must meet stringent analytical-grade standards to ensure accuracy in techniques like atomic absorption spectroscopy (AAS), inductively coupled plasma mass spectrometry (ICP-MS), and chromatography, manufacturers face challenges in maintaining consistent quality while managing rising production costs. All these factors hamper Australia and New Zealand acids market growth.
The growing focus on drug discovery, biopharmaceuticals, and vaccine development has increased the demand for precise analytical techniques that rely on ultra-pure acids such as nitric acid, hydrochloric acid, sulfuric acid, and perchloric acid. For instance, Commonwealth Scientific and Industrial Research Organisation inaugurated a $23.1 million National Vaccine and Therapeutics Lab in Melbourne. This lab addresses a critical gap in Australia's biomedical sector by enabling the onshore production of vaccines and therapeutics for clinical trials, thereby accelerating the translation of research into viable medical products. Acids play a crucial role in pharmaceutical research by enabling accurate sample preparation, digestion, and chemical analysis in methods such as high-performance liquid chromatography (HPLC), atomic absorption spectroscopy (AAS), and inductively coupled plasma mass spectrometry (ICP-MS). Their ability to ensure the purity, stability, and compliance of pharmaceutical products with stringent regulatory standards makes them essential in both research and manufacturing processes. All these factors are anticipated to offer new growth opportunities for the Australia and New Zealand acids market during the forecast period.
Segments Overview
The Australia and New Zealand acids market is segmented into type and country. On the basis of acid type, market is classified into instrumental analysis, research, and QC. Country-wise, the market is segmented into Australia and New Zealand.
On the basis of type, market is classified into instrumental analysis, research, and QC. Instrument analysis segment accounted for less than two-fifths of the Australia and New Zealand acids market share in 2023 and is expected to maintain its dominance during the forecast period. High-purity acids, such as hydrochloric acid, nitric acid, and sulfuric acid, are essential for dissolving, digesting, and stabilizing samples in laboratories, ensuring accurate and reliable results. Their use in spectroscopy, chromatography, and titration processes is fundamental for precise measurements in industries such as pharmaceuticals, environmental monitoring, and materials science. Moreover, advancements in analytical instrumentation, such as inductively coupled plasma mass spectrometry (ICP-MS) and atomic absorption spectroscopy (AAS), have increased the need for ultra-high-purity acids to minimize interference and enhance detection sensitivity.
Country-wise, the market is segmented into Australia and New Zealand. The Australia country accounted for more than four-fifths of the Australia and New Zealand acids market share in 2023 and is expected to maintain its dominance during the forecast period. The growth of sectors such as biotechnology, nanotechnology, and forensic science is fueling the demand for ultrapure acids, particularly in Australia’s research-driven economy. In addition, sustainability initiatives and the push for green chemistry practices are encouraging the adoption of environmentally friendly acid formulations with reduced impurities, supporting ongoing innovation in analytical research and quality control applications.
Competitive Analysis
Key players in the Australia and New Zealand acids market include ACE Chemical Company, Agilent Technologies, Australian Scientific Pty Ltd, ChemSupply Australia, Hach, Honeywell International Inc, Rowe Scientific Pty Ltd, SHIMADZU CORPORATION, Thermo Fisher Scientific Inc., and Westlab Pty. Ltd.
In the Australia and New Zealand acids market, companies have adopted investment strategy to expand the market or develop new products. For instance, in January 2023, Agilent Technologies Inc. announced an investment of approximately $725 million to double the manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).
Key Benefits of Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Australia and New Zealand acids market analysis from 2023 to 2033 to identify the prevailing Australia and New Zealand acids market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the Australia and New Zealand acids market statistics and segmentation assists to determine the prevailing market opportunities.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the Australia and New Zealand acids market trends, key players, market segments, application areas, and market growth strategies. The research methodology of the global market involves extensive primary and secondary research. Primary research includes about over 12 hours of interviews and discussion with a wide range of stakeholders, including upstream and downstream participants. The primary research typically is the bulk of our research efforts; however, coherently supported by extensive secondary research. Researchers have reviewed over 6,765 product literatures, industry releases, annual reports, and other such documents of key industry participants to obtain better market understanding and gain competitive intelligence. In addition, authentic industry journals, trade associations' releases,and government websites have also been reviewed for generating high-value industry insights.
Table of Contents
179 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report Description
- 1.2.Key benefits for stakeholders
- 1.3.Key market segments
- 1.4.Research methodology
- 1.4.1.Primary research
- 1.4.2.Secondary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings
- 2.1.1.Top investment pockets
- 2.2.CXO perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Porter’s Five Forces Analysis
- 3.3.Market dynamics
- 3.3.1.Drivers
- 3.3.1.1.Expansion of the chemical industry
- 3.3.1.2.Advancements in research and development
- 3.3.2.Restraint
- 3.3.2.1.Volatility in raw material prices
- 3.3.3.Opportunity
- 3.3.3.1.Advancements in pharmaceutical research
- 3.4.Value chain analysis
- 3.5.Regulatory Guidelines
- 3.6.Qualitative Information about the factors affecting the acids market in Australia and New Zealand
- 3.7.Patent landscape
- 3.8.Average Selling Pricing Analysis, for Australia and New Zealand, 2023, by Key Players
- 3.9.Pricing Analysis
- CHAPTER 4:AUSTRALIA AND NEW ZEALAND ACIDS MARKET, BY ACID TYPE
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.For Instrumental Analysis
- 4.2.1.Key Market Trends, Growth Factors and Opportunities
- 4.2.2.Market size and forecast, by Instrumental Analysis
- 4.2.2.1.Nitric Acid
- 4.2.2.1.1.Market Size and Forecast, by Country
- 4.2.2.2.Formic Acid
- 4.2.2.2.1.Market Size and Forecast by Country
- 4.2.2.3.Acetic Acid
- 4.2.2.3.1.Market Size and Forecast by Country
- 4.2.2.4.Hydrochloric Acid
- 4.2.2.4.1.Market Size and Forecast by Country
- 4.2.2.5.Sulfuric Acid
- 4.2.2.5.1.Market Size and Forecast by Country
- 4.3.For Research
- 4.3.1.Key Market Trends, Growth Factors and Opportunities
- 4.3.2.Market size and forecast, Research
- 4.3.2.1.Nitric Acid
- 4.3.2.1.1.Market Size and Forecast, by Country
- 4.3.2.2.Hydrochloric Acid
- 4.3.2.2.1.Market Size and Forecast, by Country
- 4.3.2.3.Sulfuric Acid
- 4.3.2.3.1.Market Size and Forecast, by Country
- 4.3.2.4.Formic Acid
- 4.3.2.4.1.Market Size and Forecast, by Country
- 4.3.2.5.Phosphoric Acid
- 4.3.2.5.1.Market Size and Forecast, by Country
- 4.3.2.6.Perchloric Acid
- 4.3.2.6.1.Market Size and Forecast, by Country
- 4.3.2.7.Acetic Acid
- 4.3.2.7.1.Market Size and Forecast, by Country
- 4.4.For QC
- 4.4.1.Key Market Trends, Growth Factors and Opportunities
- 4.4.2.Market size and forecast, by QC
- 4.4.2.1.Nitric Acid
- 4.4.2.1.1.Market Size and Forecast, by Country
- 4.4.2.2.Acetic Acid
- 4.4.2.2.1.Market Size and Forecast, by Country
- 4.4.2.3.Sulfuric Acid
- 4.4.2.3.1.Market Size and Forecast, by Country
- 4.4.2.4.Hydrochloric Acid
- 4.4.2.4.1.Market Size and Forecast, by Country
- 4.4.2.5.Formic Acid
- 4.4.2.5.1.Market Size and Forecast, by Country
- 4.4.2.6.Boric Acid
- 4.4.2.6.1.Market Size and Forecast, by Country
- 4.4.2.7.Citric Acid
- 4.4.2.7.1.Market Size and Forecast, by Country
- CHAPTER 5:AUSTRALIA AND NEW ZEALAND ACIDS MARKET, BY COUNTRY
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Australia
- 5.2.1.Key market trends, growth factors, and opportunities
- 5.2.1.1.Market Size and Forecast, By Acid Type
- 5.2.1.2.Market Size and Forecast, By Instrument Analysis
- 5.2.1.3.Market Size and Forecast, By Research
- 5.2.1.4.Market Size and Forecast, By QC
- 5.3.New Zealand
- 5.3.1.Key market trends, growth factors, and opportunities
- 5.3.1.1.Market Size and Forecast, By Acid Type
- 5.3.1.2.Market Size and Forecast, By Instrument Analysis
- 5.3.1.3.Market Size and Forecast, By Research
- 5.3.1.4.Market Size and Forecast, By QC
- CHAPTER 6:COMPETITIVE LANDSCAPE
- 6.1.Introduction
- 6.2.Top winning strategies
- 6.2.1.Top winning strategies, by year, 2021-2023*
- 6.2.2.Top winning strategies, by development, 2021-2023*(%)
- 6.2.3.Top winning strategies, by company, 2021-2023*
- 6.3.Product mapping of top 10 player
- 6.4.Competitive Dashboard
- 6.5.Competitive heatmap
- 6.6.Top player positioning
- CHAPTER 7:COMPANY PROFILES
- 7.1.ACE CHEMICAL COMPANY
- 7.1.1.Company overview
- 7.1.2.Key executives
- 7.1.3.Company snapshot
- 7.1.4.Operating Product segments
- 7.1.5.Product portfolio
- 7.2.AGILENT TECHNOLOGIES INC.
- 7.2.1.Company overview
- 7.2.2.Company snapshot
- 7.2.3.Operating business segments
- 7.2.4.Business performance
- 7.2.5.Product portfolio
- 7.2.6.Key strategic moves and developments
- 7.3.AUSTRALIAN SCIENTIFIC PTY LTD.
- 7.3.1.Company overview
- 7.3.2.Key executives
- 7.3.3.Company snapshot
- 7.3.4.Operating business segments
- 7.3.5.Product portfolio
- 7.4.CHEMSUPPLY AUSTRALIA
- 7.4.1.Company overview
- 7.4.2.Key executives
- 7.4.3.Company Snapshot
- 7.4.4.Operating business segments
- 7.4.5.Product portfolio
- 7.5.HACH
- 7.5.1.Company overview
- 7.5.2.Key executives
- 7.5.3.Company snapshot
- 7.5.4.Operating business segments
- 7.5.5.Product portfolio
- 7.6.HONEYWELL INTERNATIONAL INC.
- 7.6.1.Company overview
- 7.6.2.Key executives
- 7.6.3.Company snapshot
- 7.6.4.Operating business segments
- 7.6.5.Business performance
- 7.6.6.Product portfolio
- 7.7.SHIMADZU CORPORATION
- 7.7.1.Company overview
- 7.7.2.Key executives
- 7.7.3.Company snapshot
- 7.7.4.Operating business segments
- 7.7.5.Business performance
- 7.7.6.Product portfolio
- 7.8.THERMO FISHER SCIENTIFIC INC.
- 7.8.1.Company overview
- 7.8.2.Key executives
- 7.8.3.Company snapshot
- 7.8.4.Operating business segments
- 7.8.5.Business performance
- 7.8.6.Product portfolio
- 7.9.WESTLAB PTY. LTD
- 7.9.1.Company overview
- 7.9.2.Key executives
- 7.9.3.Company snapshot
- 7.10.ROWE SCIENTIFIC PTY LTD.
- 7.10.1.Company overview
- 7.10.2.Key executives
- 7.10.3.Company snapshot
- 7.10.4.Operating business segments
- 7.10.5.Product portfolio
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
